FDA approves first gene therapy for genetic hearing loss

The Food and Drug Administration on Thursday approved Regeneron’s Otarmeni, the first gene therapy for genetic hearing loss

Berkeley Lovelace Jr.
Author: Berkeley Lovelace Jr.

Written by

Berkeley Lovelace Jr.

in

More posts